dc.contributor.author |
Guðmundsson, Aðalsteinn |
dc.date.accessioned |
2023-10-11T01:07:44Z |
dc.date.available |
2023-10-11T01:07:44Z |
dc.date.issued |
2023-10 |
dc.identifier.citation |
Guðmundsson , A 2023 , ' Fjöllyfjameðferð : Vogarskálar ávinnings og skaða? ' , Læknablaðið , bind. 109 , nr. 10 , bls. 435 . https://doi.org/10.17992/lbl.2023.10.759 |
dc.identifier.issn |
1670-4959 |
dc.identifier.other |
195838805 |
dc.identifier.other |
11a89975-e501-4048-be79-aa2ab45fa24d |
dc.identifier.other |
37767931 |
dc.identifier.other |
85172772802 |
dc.identifier.other |
unpaywall: 10.17992/lbl.2023.10.759 |
dc.identifier.other |
85175553499 |
dc.identifier.uri |
https://hdl.handle.net/20.500.11815/4484 |
dc.format.extent |
1 |
dc.format.extent |
916846 |
dc.format.extent |
435 |
dc.language.iso |
is |
dc.relation.ispartofseries |
Læknablaðið; 109(10) |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
Öldrunarlæknisfræði |
dc.subject |
Humans |
dc.subject |
Polypharmacy |
dc.subject |
Almenn læknisfræði |
dc.title |
Fjöllyfjameðferð : Vogarskálar ávinnings og skaða? |
dc.title.alternative |
PolypharmacyBenefit or harm? |
dc.type |
/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/editorial |
dc.identifier.doi |
10.17992/lbl.2023.10.759 |
dc.relation.url |
http://www.scopus.com/inward/record.url?scp=85175553499&partnerID=8YFLogxK |
dc.contributor.department |
Önnur svið |